Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (69995) 69995
Book Review (12779) 12779
Publication (2600) 2600
Newsletter (1895) 1895
Magazine Article (513) 513
Conference Proceeding (336) 336
Book Chapter (169) 169
Book / eBook (75) 75
Newspaper Article (73) 73
Dissertation (42) 42
Trade Publication Article (32) 32
Reference (29) 29
Transcript (24) 24
Web Resource (23) 23
Paper (7) 7
Government Document (3) 3
Data Set (2) 2
Archival Material (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58792) 58792
humans (53338) 53338
antihypertensive agents - therapeutic use (38343) 38343
male (32528) 32528
hypertension - drug therapy (30325) 30325
female (27367) 27367
middle aged (21283) 21283
hypertension (20695) 20695
aged (17218) 17218
blood pressure - drug effects (15339) 15339
adult (14854) 14854
animals (14035) 14035
antihypertensive agents - pharmacology (13637) 13637
hypertension - physiopathology (10881) 10881
antihypertensive agents - administration & dosage (10056) 10056
blood pressure (9720) 9720
rats (8807) 8807
peripheral vascular disease (8765) 8765
risk factors (8365) 8365
antihypertensive agents - adverse effects (8351) 8351
pharmacology & pharmacy (8069) 8069
treatment outcome (8025) 8025
hypertension - complications (6973) 6973
antihypertensive drugs (6777) 6777
abridged index medicus (6703) 6703
blood-pressure (6386) 6386
antihypertensive agents (6284) 6284
drug therapy, combination (5763) 5763
medicine, general & internal (5225) 5225
cardiac & cardiovascular systems (5219) 5219
time factors (4525) 4525
aged, 80 and over (4517) 4517
drug therapy (4463) 4463
angiotensin-converting enzyme inhibitors - therapeutic use (4357) 4357
hypertension - diagnosis (3782) 3782
research (3679) 3679
mortality (3534) 3534
hypertension - epidemiology (3470) 3470
double-blind method (3463) 3463
prospective studies (3356) 3356
dose-response relationship, drug (3353) 3353
risk (3208) 3208
follow-up studies (3194) 3194
care and treatment (3182) 3182
prevalence (3146) 3146
heart rate - drug effects (3133) 3133
blood pressure - physiology (3036) 3036
calcium channel blockers - therapeutic use (2948) 2948
hypertension - therapy (2825) 2825
adolescent (2799) 2799
ophthalmology (2740) 2740
clinical trials as topic (2694) 2694
adrenergic beta-antagonists - therapeutic use (2659) 2659
therapy (2636) 2636
retrospective studies (2585) 2585
management (2566) 2566
diuretics - therapeutic use (2560) 2560
medicine & public health (2509) 2509
analysis (2484) 2484
hypertension - etiology (2452) 2452
prevention (2447) 2447
disease (2419) 2419
old medline (2412) 2412
rats, inbred shr (2409) 2409
diuretics (2403) 2403
randomized controlled trials as topic (2265) 2265
health aspects (2218) 2218
angiotensin (2113) 2113
prognosis (2044) 2044
cardiovascular diseases - prevention & control (2038) 2038
angiotensin receptor antagonists (2033) 2033
diabetes (2018) 2018
age factors (2000) 2000
hemodynamics - drug effects (1986) 1986
urology & nephrology (1965) 1965
pregnancy (1944) 1944
stroke (1942) 1942
internal medicine (1940) 1940
rats, sprague-dawley (1845) 1845
patient compliance (1840) 1840
hypertension, pulmonary - drug therapy (1830) 1830
losartan (1830) 1830
drugs (1817) 1817
intraocular pressure - drug effects (1794) 1794
tetrazoles - therapeutic use (1786) 1786
drug combinations (1728) 1728
trial (1718) 1718
hypertension - blood (1708) 1708
practice guidelines as topic (1698) 1698
glaucoma (1691) 1691
antihypertensive agents - pharmacokinetics (1686) 1686
renin-angiotensin system - drug effects (1683) 1683
cross-sectional studies (1669) 1669
cardiovascular disease (1658) 1658
hypertension - prevention & control (1645) 1645
blood pressure monitoring, ambulatory (1642) 1642
rats, wistar (1627) 1627
angiotensin-converting enzyme inhibitors - pharmacology (1596) 1596
hypertension - metabolism (1554) 1554
cardiology (1546) 1546
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Baycrest Hospital - Wellness Library (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60994) 60994
German (2836) 2836
French (1788) 1788
Russian (1685) 1685
Japanese (1045) 1045
Spanish (988) 988
Italian (799) 799
Chinese (523) 523
Polish (387) 387
Portuguese (227) 227
Swedish (227) 227
Danish (191) 191
Czech (174) 174
Dutch (167) 167
Norwegian (155) 155
Hungarian (147) 147
Romanian (120) 120
Ukrainian (66) 66
Croatian (57) 57
Hebrew (57) 57
Finnish (56) 56
Bulgarian (51) 51
Turkish (43) 43
Serbian (35) 35
Slovak (32) 32
Korean (20) 20
Lithuanian (9) 9
Bosnian (4) 4
Icelandic (2) 2
Slovenian (2) 2
Afrikaans (1) 1
Armenian (1) 1
Greek (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Antihypertensive agents
by Conolly, Matthew E and Gross, F and Gross, F. H and Gross, Franz
1977, Handbook of experimental pharmacology : New series, ISBN 9783540075943, Volume 39., xiv, 779
Hypotensive agents
Book
Details down arrow
2. Antihypertensive agents
by Schlittler, Emil
1967, Medicinal chemistry : a series of monographs, Volume 7., xvi, 534
Hypotensive agents
Book
Details down arrow
3. Full Text Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial
by Nissen, Steven E and Tuzcu, E. Murat and Libby, Peter and Thompson, Paul D and Ghali, Magdi and Garza, Dahlia and Berman, Lance and Shi, Harry and Buebendorf, Ethel and Topol, Eric J and CAMELOT Investigators, for the and CAMELOT Investigators
JAMA, ISSN 0098-7484, 11/2004, Volume 292, Issue 18, pp. 2217 - 2225
CONTEXT The effect of antihypertensive drugs on cardiovascular events in patients with coronary artery disease (CAD) and normal blood pressure remains... 
AMLODIPINE | MORTALITY | MEDICINE, GENERAL & INTERNAL | MULTICENTER | METAANALYSIS | REDUCTION | ATHEROSCLEROSIS | OUTCOMES | HYPERTENSIVE PATIENTS | PROGRESSION | Blood Pressure | Antihypertensive Agents - pharmacology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Ultrasonography, Interventional | Male | Coronary Artery Disease - drug therapy | Antihypertensive Agents - therapeutic use | Enalapril - therapeutic use | Amlodipine - therapeutic use | Coronary Artery Disease - diagnostic imaging | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronary Artery Disease - physiopathology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Female | Aged | Heart | Care and treatment | Research | Coronary heart disease | Cardiac patients | Abnormalities | Clinical trials | Prescription drugs | Cardiovascular disease | Side effects | Blood pressure | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
by Yusuf, Salim, Prof and Islam, Shofiqul, MSc and Chow, Clara K, PhD and Rangarajan, Sumathy, MSc and Dagenais, Gilles, Prof and Diaz, Rafael, MD and Gupta, Rajeev, PhD and Kelishadi, Roya, Prof and Iqbal, Romaina, PhD and Avezum, Alvaro, MD and Kruger, Annamarie, Prof and Kutty, Raman, Prof and Lanas, Fernando, MD and Lisheng, Liu, Prof and Wei, Li, Prof and Lopez-Jaramillo, Patricio, Prof and Oguz, Aytekin, MD and Rahman, Omar, Prof and Swidan, Hany, MD and Yusoff, Khalid, Prof and Zatonski, Witold, Prof and Rosengren, Annika, Prof and Teo, Koon K, Prof and PURE Study Investigators and Prospective Urban Rural Epidemiology (PURE) Study Investigators and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Pharmaceutical chemistry of antihypertensive agents
by Szász, György and Budvári-Bárány, Susanne and Bárány, Susanne Budvári
1991, ISBN 0849347246, 276
Hypotensive agents | Pharmaceutical chemistry | Cardiovascular agents
Book
Details down arrow
6. Full Text Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes—Network meta-analysis of randomized trials
by Remonti, Luciana R and Dias, Sofia and Leitão, Cristiane B and Kramer, Caroline K and Klassman, Lucas P and Welton, Nicky J and Ades, A.E and Gross, Jorge L
Journal of Diabetes and Its Complications, ISSN 1056-8727, 08/2016, Volume 30, Issue 6, pp. 1192 - 1200
The aim of this study was to evaluate the effects of antihypertensive drug classes in mortality in patients with type 2 diabetes. MEDLINE, EMBASE, Clinical... 
Type 2 diabetes | Hypertension | Antihypertensive drugs | Metanalysis | Mortality | SYSTOLIC HYPERTENSION | EVENTS | CARDIOVASCULAR MORBIDITY | BLOOD-PRESSURE | CONSISTENCY | HIGH-RISK | MICROALBUMINURIA | ENDOCRINOLOGY & METABOLISM | OVERT NEPHROPATHY | MULTIPLE TREATMENTS | CLINICAL-OUTCOMES | Blood Pressure | Humans | Hypertension - drug therapy | Hypertension - mortality | Antihypertensive Agents - classification | Network Meta-Analysis | Antihypertensive Agents - therapeutic use | Diabetes Mellitus, Type 2 - complications | Randomized Controlled Trials as Topic | Analysis | Patient outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effect of Antihypertensive Agents on Blood Pressure Variability: The Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study
by Zhang, Yi and Agnoletti, Davide and Safar, Michel E and Blacher, Jacques
Hypertension, ISSN 0194-911X, 08/2011, Volume 58, Issue 2, pp. 155 - 160
To investigate the effect of different antihypertensive agents on blood pressure (BP) variability (BPV) and the underlying mechanism, we analyzed the... 
blood pressure variability | diuretics | heart rate variability | calcium channel blocker | Ambulatory blood pressure monitoring | MORTALITY | CARDIOVASCULAR EVENTS | ATHEROSCLEROSIS | OHASAMA | DAMAGE | ambulatory blood pressure monitoring | DISTENSIBILITY | GENERAL-POPULATION | RISK-FACTOR | EUROPEAN LACIDIPINE | PERIPHERAL VASCULAR DISEASE | PROGNOSTIC-SIGNIFICANCE | Humans | Middle Aged | Indapamide - therapeutic use | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Heart Rate - drug effects | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Female | Tetrazoles - therapeutic use | Aged | Blood Pressure - drug effects | Blood Pressure Monitoring, Ambulatory | Amlodipine - administration & dosage | Delayed-Action Preparations | Indapamide - administration & dosage | Benzimidazoles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-analysis
by Psaty, Bruce M and Lumley, Thomas and Furberg, Curt D and Schellenbaum, Gina and Pahor, Marco and Alderman, Michael H and Weiss, Noel S
JAMA, ISSN 0098-7484, 05/2003, Volume 289, Issue 19, pp. 2534 - 2544
CONTEXT Establishing relative benefit or harm from specific antihypertensive agents is limited by the complex array of studies that compare treatments. Network... 
MEDICINE, GENERAL & INTERNAL | CHRONIC STABLE ANGINA | HEART-FAILURE | RANDOMIZED-TRIAL | MILD HYPERTENSION | CALCIUM-ANTAGONISTS | BETA-BLOCKERS | CARDIOVASCULAR MORBIDITY | CONVERTING-ENZYME-INHIBITORS | BLOOD-PRESSURE | PRACTICE GUIDELINES COMMITTEE | Risk Assessment | Angiotensin Receptor Antagonists | Humans | Calcium Channel Blockers - therapeutic use | Adrenergic alpha-Antagonists - therapeutic use | Hypertension - drug therapy | Treatment Outcome | Antihypertensive Agents - therapeutic use | Randomized Controlled Trials as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - mortality | Diuretics - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hypertension | Diuretics | Antihypertensive drugs | Evaluation | Cookery for hypertensives | Drug therapy | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Prazosin, evaluation of a new anti-hypertensive agent
: proceedings of a symposium held at the Centre interprofessionnel, Geneva, 8 March, 1974
by Cotton, Dennis W. K
1974, International congress series, Volume no. 331, 166
Prazosin | Hypotensive agents | Congresses
Book
Details down arrow
10. Full Text Treatment Intensification and Risk Factor Control toward More Clinically Relevant Quality Measures
by Joseph V. Selby and Connie S. Uratsu and Bruce Fireman and Julie A. Schmittdiel and Tiffany Peng and Nicolas Rodondi and Andrew J. Karter and Eve A. Kerr
Medical Care, ISSN 0025-7079, 4/2009, Volume 47, Issue 4, pp. 395 - 402
Background: Intensification of pharmacotherapy in persons with poorly controlled chronic conditions has been proposed as a clinically meaningful process... 
Hypertension | Hyperlipidemias | Trajectory control | Diabetes mellitus | Ales | Predisposing factors | Medications | Internships | Diabetes | Hemoglobins | Cardiovascular disease | Hyperlipidemia | Quality of health care | UNITED-STATES | cardiovascular disease | hyperlipidemia | quality of health care | MANAGEMENT | CHOLESTEROL | HYPERTENSION CONTROL | TRANSLATING RESEARCH | diabetes mellitus | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | BLOOD-PRESSURE CONTROL | HEALTH POLICY & SERVICES | CORONARY-HEART-DISEASE | hypertension | TYPE-2 DIABETES-MELLITUS | OF-CARE | PERFORMANCE-MEASURES | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Hyperlipidemias - drug therapy | Middle Aged | Risk Factors | Diabetes Mellitus - drug therapy | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | California | Antihypertensive Agents - therapeutic use | Managed Care Programs | Outcome and Process Assessment (Health Care) | Drug Therapy - standards | Hypoglycemic Agents - administration & dosage | Drug Therapy - methods | Hypolipidemic Agents - administration & dosage | Female | Aged | Hypolipidemic Agents - therapeutic use | Quality Indicators, Health Care - standards | Chronic Disease - drug therapy | Performance evaluation | Validity | Drug therapy | Risk factors | Quality of care | Chronic illnesses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Low-Dose Quadruple Antihypertensive Combination: More Efficacious Than Individual Agents-A Preliminary Report
by Mahmud, Azra and Feely, John
Hypertension, ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 272 - 275
Increasingly combined antihypertensive agents are being used in practice to enhance control and improve compliance. To determine whether a capsule containing a... 
Hypertension | Antihypertensive drugs | Blood pressure | Antihypertensive combinations | antihypertensive drugs | blood pressure | TRIALS | antihypertensive combinations | EVENTS | PREVENTION | PERIPHERAL VASCULAR DISEASE | JOINT NATIONAL COMMITTEE | hypertension | HIGH BLOOD-PRESSURE | 7TH REPORT | Diuretics - administration & dosage | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology | Captopril - administration & dosage | Capsules | Calcium Channel Blockers - administration & dosage | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Drug Combinations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Antihypertensive agents and risk of Parkinson's disease: A nationwide cohort study
by Lee, Yen-Chieh and Lin, Chin-Hsien and Wu, Ruey-Meei and Lin, Jou-Wei and Chang, Chia-Hsuin and Lai, Mei-Shu
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e98961 - e98961
Background and Purpose: Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to... 
OXIDATIVE STRESS | INHIBITION | MANAGEMENT | MPTP MODEL | MULTIDISCIPLINARY SCIENCES | HYPERTENSION | CALCIUM-CHANNEL BLOCKERS | ANGIOTENSIN-CONVERTING ENZYME | ASSOCIATION | BLOOD-PRESSURE | DEGENERATION | Antihypertensive Agents - pharmacology | Humans | Angiotensin Receptor Antagonists - pharmacology | Proportional Hazards Models | Male | Risk | Calcium Channel Blockers - pharmacology | Parkinson Disease - prevention & control | Taiwan - epidemiology | Parkinson Disease - epidemiology | Female | Aged | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Cohort Studies | Hypertension | Medical research | Enzymes | Calcium channels | Enzyme inhibitors | National health insurance | Angiotensin | Medicine, Experimental | Risk factors | Dementia | Antiparkinsonian agents | Felodipine | Drugs | Parkinson's disease | Calcium | Drug development | Incidence | Regression models | Peptidyl-dipeptidase A | Dementia disorders | Blood pressure | Dihydropyridine | Antihypertensive agents | Movement disorders | Health insurance | Stroke | Neurodegenerative diseases | Health risks | Risk reduction | Preventive medicine | Patients | Health risk assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Handbook of cardiac drugs
: basic science and clinical aspects of cardiovascular pharmacology
by Purdy, Ralph E and Boucek, Robert J., 1919
1988, 1st ed. --, ISBN 0316722456, xix, 375
Heart | Chemotherapy | Handbooks, manuals, etc | Cardiovascular agents | Diseases
Book
Details down arrow
14. Full Text Hypertension impairs postnatal vasculogenesis role of antihypertensive agents
by You, Dong and Cochain, Clément and Loinard, Céline and Vilar, Jose Manuel and Mees, Barend and Duriez, Micheline and Levy, Bernard and Silvestre, Jean Sebastien
Hypertension, ISSN 0194-911X, 06/2008, Volume 51, Issue 6, pp. 1537 - 1544
textabstractWe analyzed the effect of hypertension on postischemic vasculogenesis. Ischemia was induced by right femoral artery ligature in Wistar Kyoto rats... 
Hypertension | Angiogenesis | Progenitor cells | Angiotensin converting enzyme | Angiotensin type i receptor | CORONARY MICROVASCULATURE | angiogenesis | II TYPE-1 RECEPTOR | ACE-INHIBITOR | RATS | progenitor cells | ANGIOTENSIN-II | ENDOTHELIAL PROGENITOR CELLS | CONVERTING ENZYME-INHIBITION | angiotensin converting enzyme | VASCULAR FUNCTION | PERIPHERAL VASCULAR DISEASE | angiotensin type I receptor | NEOVASCULARIZATION | hypertension | Endothelium, Vascular - cytology | Neovascularization, Physiologic - drug effects | Antihypertensive Agents - pharmacology | Hydralazine - pharmacology | Oxidative Stress - physiology | Bone Marrow Cells - physiology | Rats, Inbred WKY | Hypertension - drug therapy | Male | Stem Cells - cytology | Endothelium, Vascular - physiology | Perindopril - pharmacology | Ligation | Blood Pressure - drug effects | Blood Pressure - physiology | Cell Differentiation - physiology | Ischemia - pathology | Disease Models, Animal | Rats, Inbred SHR | Bone Marrow Cells - cytology | Losartan - pharmacology | Rats | Ischemia - physiopathology | Hypertension - pathology | Hypertension - physiopathology | Neovascularization, Physiologic - physiology | Animals | Hindlimb - blood supply | Stem Cells - physiology | Oxidative Stress - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Antitumoral, antihypertensive, antimicrobial, and antioxidant effects of an octanuclear copper(II)-telmisartan complex with an hydrophobic nanometer hole
by Islas, María S and Martínez Medina, Juan J and López Tévez, Libertad L and Rojo, Teófilo and Lezama, Luis and Griera Merino, Mercedes and Calleros, Laura and Cortes, María A and Rodriguez Puyol, Manuel and Echeverría, Gustavo A and Piro, Oscar E and Ferrer, Evelina G and Williams, Patricia A. M
Inorganic Chemistry, ISSN 0020-1669, 06/2014, Volume 53, Issue 11, pp. 5724 - 5737
A new Cu(II) complex with the antihypertensive drug telmisartan, [Cu(8)Tlm(16)]center dot 24H(2)O (CuTlm), was synthesized and characterized by elemental... 
COPPER(II) COMPLEXES | ACID | HUMAN MESANGIAL CELLS | ANTIBACTERIAL ACTIVITY | CRYSTAL-STRUCTURE | PROSTATE-CANCER CELLS | ANGIOTENSIN-II | DIFFUSION | HYPERTENSION | II RECEPTOR BLOCKERS | CHEMISTRY, INORGANIC & NUCLEAR | Cell Line | Antihypertensive Agents - pharmacology | Antioxidants - chemistry | Apoptosis - drug effects | Antineoplastic Agents - chemical synthesis | Benzoates - chemistry | Humans | Bacteria - drug effects | Models, Molecular | Antihypertensive Agents - chemical synthesis | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Nanostructures | Antineoplastic Agents - chemistry | Benzimidazoles - chemistry | Anti-Bacterial Agents - chemical synthesis | Microbial Sensitivity Tests | Antihypertensive Agents - chemistry | Copper - chemistry | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Molecular Structure | Copper compounds | Chemical properties | Hydrophobicity | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights